Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cAMP response element-binding protein (CREB)-mediated transcriptional machinery is a multi-protein assembly essential for converting cellular signals into long-term changes in gene expression. At its core, the transcription factor CREB binds to cAMP response elements (CRE) in DNA and, upon activation by phosphorylation at Ser133, recruits coactivators such as CREB-binding protein (CBP) and p300 (UniProt P16220, Q92793). These coactivators facilitate transcription by acting as scaffolds for the basal transcription machinery and by acetylating histones to open chromatin structure (PubMed: 15107404). This machinery is vital for biological processes such as neuronal plasticity, memory formation, and metabolic regulation. In disease contexts, overactivation of this machinery is linked to the progression of various cancers, including acute myeloid leukemia and prostate cancer, while its impairment is associated with neurodegenerative conditions like Alzheimer's disease (PubMed: 30249655). Pharmacological targeting of this machinery typically involves small molecules that disrupt the CREB-CBP interaction or inhibit the acetyltransferase activity of CBP/p300 to modulate the expression of oncogenic or survival-related genes (PubMed: 25105510).
Inhibition of the protein-protein interaction between CREB and its coactivators (CBP/p300) or inhibition of the histone acetyltransferase (HAT) activity of the coactivators to suppress downstream gene expression.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on cAMP response element-binding protein-mediated transcriptional machinery (CREB complex) (CREB complex).